We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Davies and Welch Draw Unfounded Conclusions about Thyroid Cancer from Epidemiological Data—Reply

Louise Davies, MD, MS1,2,3; H. Gilbert Welch, MD, MPH3
[+] Author Affiliations
1VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, Vermont
2Section of Otolaryngology in Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
3Dartmouth Institute for Health Policy and Clinical Practice, Hanover, New Hampshire
JAMA Otolaryngol Head Neck Surg. 2014;140(7):679. doi:10.1001/jamaoto.2014.948.
Text Size: A A A
Published online


In Reply Ms Banach suggests that improvements in diagnosis and treatment over the past 30 years might explain a stable thyroid cancer mortality rate in the face of skyrocketing incidence. We1 agree that this is “possible,” but it is not plausible. To produce stable mortality, these improvements would have had to exactly match the change in incidence rate. If the improvements occurred too fast, mortality would fall; if the improvements occurred too slowly, mortality would rise. The most parsimonious explanation is that the vast reservoir of subclinical cancer is increasingly being detected, and this newly diagnosed disease is not destined to cause death.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





July 1, 2014
Rita Banach, BSc, DCS
1Thyroid Cancer Canada, Toronto, Ontario, Canada
JAMA Otolaryngol Head Neck Surg. 2014;140(7):678-679. doi:10.1001/jamaoto.2014.942.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...